1-Year Comparison of Clinical and Endoscopic Outcomes of Tofacitinib vs Vedolizumab for Ulcerative Colitis After Anti-Tumor Necrosis Factor Failure: A Real-World Cohort Study in the United States

被引：0
|
作者：
Dalal, Rahul S. [1 ]
Sharma, Puza P. [2 ]
Bains, Kanwal [3 ]
Pruce, Jordan C. [1 ]
Allegretti, Jessica R. [1 ,4 ]
机构：
[1] Harvard Med Sch, Brigham & Womens Hosp, Dept Med, Div Gastroenterol Hepatol & Endoscopy, Boston, MA USA
[2] Pfizer Inc, New York, NY USA
[3] Harvard Med Sch, Brigham & Womens Hosp, Dept Nutr, Boston, MA USA
[4] 50 Boylston St,Suite 201, Chestnut Hill, MA 02467 USA
来源：
INFLAMMATORY BOWEL DISEASES | 2023年 / 30卷 / 08期
关键词：
inflammatory bowel disease; small molecule; biologic; MAINTENANCE THERAPY; INDUCTION;
D O I：
10.1093/ibd/izad165
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
In this retrospective cohort study, tofacitinib was associated with higher adjusted odds of steroid-free clinical remission at 52 weeks and endoscopic remission within 52 weeks compared with vedolizumab. Adverse events were consistent with the known safety profiles of these agents.
引用
收藏
页码：1419 / 1422
页数：4
相关论文
共 8 条
  • [1] 1-Year Comparative Effectiveness of Tofacitinib vs Ustekinumab for Patients With Ulcerative Colitis and Prior Antitumor Necrosis Factor Failure
    Dalal, Rahul S.
    Sharma, Puza P.
    Bains, Kanwal
    Pruce, Jordan C.
    Allegretti, Jessica R.
    INFLAMMATORY BOWEL DISEASES, 2024, 30 (03) : 395 - 401
  • [2] Real-world clinical effectiveness and safety of vedolizumab and anti-tumor necrosis factor alpha treatment in ulcerative colitis and Crohn's disease patients: a German retrospective chart review
    Helwig, Ulf
    Mross, Michael
    Schubert, Stefan
    Hartmann, Heinz
    Brandes, Alina
    Stein, Dara
    Kempf, Christian
    Knop, Jana
    Campbell-Hill, Sarah
    Ehehalt, Robert
    BMC GASTROENTEROLOGY, 2020, 20 (01)
  • [3] Characteristics, clinical outcomes and patient-reported outcomes of patients with ulcerative colitis receiving tofacitinib: a real-world survey in the United States and five European countries
    Armuzzi, Alessandro
    Hart, Ailsa
    Cappelleri, Joseph C. C.
    Mammar, Nadir
    Hur, Peter
    Hoskin, Benjamin
    Hennessy, Fritha
    Milligan, Gary
    Dignass, Axel
    BMC GASTROENTEROLOGY, 2023, 23 (01)
  • [4] Real-world clinical effectiveness and safety of vedolizumab and anti-tumor necrosis factor alpha treatment in ulcerative colitis and Crohn’s disease patients: a German retrospective chart review
    Ulf Helwig
    Michael Mross
    Stefan Schubert
    Heinz Hartmann
    Alina Brandes
    Dara Stein
    Christian Kempf
    Jana Knop
    Sarah Campbell-Hill
    Robert Ehehalt
    BMC Gastroenterology, 20
  • [5] Propensity score-matched real-world comparative treatment outcomes of Janus kinase inhibitors for ulcerative colitis in patients with and without prior exposure to anti-tumor necrosis factor α antibody
    Ikenouchi, Maiko
    Fukui, Hirokazu
    Yagi, Soichi
    Nogami, Akira
    Kaku, Koji
    Sato, Toshiyuki
    Kawai, Mikio
    Kamikozuru, Koji
    Yokoyama, Yoko
    Takagawa, Tetsuya
    Tomita, Toshihiko
    Kobayashi, Taku
    Shinzaki, Shinichiro
    INTESTINAL RESEARCH, 2025,
  • [6] Immunomodulators after the discontinuation of anti-tumor necrosis factor-alpha antibody treatment and relapse in ulcerative colitis: A multicenter cohort study
    Asonuma, Kunio
    Ozeki, Keiji
    Yamazaki, Hajime
    Okabayashi, Shinji
    Okano, Soh
    Ozaki, Ryo
    Nishimata, Nobuaki
    Kiyohara, Hiroki
    Ichinari, Naoki
    Kobayashi, Taku
    Yamada, Masahiro
    Matsubayashi, Mao
    Yokoyama, Yoko
    Arimitsu, Shoko
    Umeno, Junji
    Munetomo, Yoshinori
    Andoh, Akira
    Shinzaki, Shinichiro
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2024, 39 (01) : 66 - 73
  • [7] Real-world Experience of Anti-tumor Necrosis Factor Therapy for Internal Fistulas in Crohn's Disease: A Retrospective Multicenter Cohort Study
    Kobayashi, Taku
    Hishida, Asahi
    Tanaka, Hiroki
    Nuki, Yoichiro
    Bamba, Shigeki
    Yamada, Akihiro
    Fujii, Toshimitsu
    Shinzaki, Shinichiro
    Yokoyama, Yoko
    Yoshida, Atsushi
    Ozeki, Keiji
    Ashizuka, Shinya
    Kamata, Noriko
    Nanjo, Sohachi
    Kakimoto, Kazuki
    Nakamura, Misaki
    Matsui, Akira
    Yamauchi, Ryosuke
    Takahashi, Sakuma
    Tomizawa, Taku
    Yoshino, Takuya
    Hibi, Toshifumi
    INFLAMMATORY BOWEL DISEASES, 2017, 23 (12) : 2245 - 2251
  • [8] Improved Clinical Outcomes With Early Anti-Tumour Necrosis Factor Alpha Therapy in Children With Newly Diagnosed Crohn's Disease: Real-world Data from the International Prospective PIBD-SETQuality Inception Cohort Study
    Klomberg, Renz C. W.
    van der Wal, Hella C.
    Aardoom, Martine A.
    Kemos, Polychronis
    Rizopoulos, Dimitris
    Ruemmele, Frank M.
    Charrout, Mohammed
    Escher, Hankje C.
    Croft, Nicholas M.
    de Ridder, Lissy
    JOURNAL OF CROHNS & COLITIS, 2024, 18 (05) : 738 - 750
1